Apotex Strengthens Leadership Structure for Future Growth

Apotex Announces Key Leadership Changes

On March 30, 2026, Apotex, a leading global health company based in Canada, revealed significant alterations to its executive leadership team aimed at reinforcing its strategic direction and propelling the next phase of growth. The transition comes as the organization strives to adapt to the evolving pharmaceutical landscape.

Allan Oberman, who has been at the helm of Apotex as President and CEO since 2023, has decided to step down from his role while continuing to influence the company as a member of its Board of Directors. Oberman’s extensive industry knowledge and leadership qualities have been pivotal in guiding Apotex through various strategic initiatives and setting long-term objectives.

In conjunction with this shift, Jeff Watson has been appointed as the new President and CEO of Apotex. Watson returns to the organization after a successful tenure as CEO from 2018 to 2023. He has been with Apotex for over two decades and, in his previous role, was instrumental in steering the company's operational strategies and business development efforts. Watson's familiarity with the corporate structure and his history of delivering successful outcomes make him a fitting choice to lead Apotex into its next chapter.

Aaron Davenport, the Chairman of the Board of Apotex, expressed confidence in the leadership changes, stating, "Allan's deep industry expertise and strong leadership have been instrumental in shaping Apotex's strategic direction. I am also thrilled to welcome Jeff back as our CEO. His track record of delivering results, combined with his commitment to patient access and industry innovation, makes him the ideal leader to ensure future growth."

These changes take effect immediately, reflecting Apotex's commitment to maintaining a robust leadership structure as they navigate current challenges within the healthcare industry. Under Watson’s leadership, Apotex is poised to capitalize on new opportunities and to continue its mission of improving patient access to affordable healthcare solutions.

About Apotex

Founded in Canada, Apotex is recognized as the largest pharmaceutical company in the country, dedicated to improving daily access to innovative medications and healthcare products. With a diverse portfolio that includes generic drugs, biosimilars, and branded pharmaceuticals, as well as consumer health products, Apotex has grown into a formidable presence in the global health arena. The company boasts a presence not only in Canada but also operates regional offices across various global markets, including the United States, Mexico, and India.

By focusing on expanding its product offerings and maintaining a patient-centered approach, Apotex continues to strategically position itself as a vital partner in the pharmaceutical sector. As they look to the future, the company remains committed to its core values of innovation, accessibility, and excellence in healthcare.

For more information about Apotex and its initiatives, visit www.apotex.com.